Golgi B1,6N-acetylglucosaminyltransferase V (Mgat5) produces B1,6GlcNAc-branched complex N-glycans on cell surface glycoproteins that bind to galectins and promote surface residency of glycoproteins, including cytokine receptors. 
Introduction
Oncogenic gain-of-function mutations in intracellular mediators of Ras/extracellular signal-regulated kinase (Erk) and phosphatidylinositol 3-kinase (PI3K)/Akt signaling stimulate cell proliferation and metabolism, thereby increasing growth autonomy by relaxing the requirements for extracellular growth factors. However, tumor cells remain dependent on extracellular cues, notably cytokines and substratum adhesion to polarize the cytoskeleton and promote epithelial-to-mesenchymal transition (EMT), a feature of invasive carcinomas (1) . Epidermal growth factor (EGF) family of growth factors binds receptor tyrosine kinases (RTK) and activates PI3K/ Erk signaling, glucose uptake, cell proliferation, and microfilament remodeling (2) . TGF-h binding to ThRII promotes Par6-Smurf1-dependent degradation of RhoA in focal regions of polarized cells, which contributes to microfilament remodeling and the mesenchymal morphology (3) . TGF-h activation of the canonical Smad2/ Smad3 transcription factor pathway induces extracellular matrix production and, at high levels, inhibits cell cycle progression (4, 5) . A balanced stimulation of RTK/Erk/PI3K and ThR/Smad2 pathways is required to sustain growth and avoid cell cycle arrest induced by the latter (6) .
Galectin-3 binds to the N-glycans on cell surface receptors, which opposes their loss to endocytosis and enhances sensitivities to cognate ligands (7) . The galectins are a family of h-galactosidebinding proteins that cross-link glycoproteins with avidities dependent on N-glycan structure and number (8) . The number of N-glycans is a feature defined by the protein sequence of each glycoprotein, whereas N-glycan structures are determined by the Golgi N-glycan processing pathway and metabolite supply to sugarnucleotide pools. Notably, fructose-6P, glutamine, and acetyl-CoA supply the hexosamine pathway for de novo UDP-N-acetylglucosamine (UDP-GlcNAc) biosynthesis, a rate-limiting substrate for N-acetylglucosaminyltransferases I, II, IV, and V [encoded by Mgat1, Mgat2, Mgat4a/b, and Golgi h1,6N-acetylglucosaminyltransferase V (Mgat5); refs. 9, 10] . These medial Golgi enzymes initiate antennae; their substitution by h1,4galactosyltransferase resulting in 0 to 4 (Galh1,4GlcNAch1) antennae with proportionate increases in affinity for galectin-3. The physical and kinetic characteristics of the N-glycan branching pathway cooperate with the number of N-glycans to differentially regulate growth [e.g., EGFR receptor (EGFR)] and arrest (e.g., TGF-h) receptors at the cell surface downstream of metabolic flux to UDP-GlcNAc biosynthesis (8) .
Mammary tumor cells derived from polyomavirus middle T (PyMT) transgenic mice on a Mgat5 À/À background are less responsive to insulin-like growth factor (IGF), EGF, platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), and TGF-h, with a reduced galectin-3 binding and shift receptors from the cell surface to the endosomes (7) . The PyMT oncoprotein is a cytosolic adaptor protein that enhances PI3K/Akt-dependent membrane remodeling (11) , which tends to reduce surface residency of glycoprotein receptors when the galectin lattice is weak. PyMT Mgat5 À/À mice display reduced metastasis in vivo and tumor cells retain an epithelial morphology in culture, but expression of Mgat5 from a retroviral vector in PyMT Mgat5 À/À tumor cells restores surface receptors, EMT, and the metastatic phenotype (7) . Tumors arise in PyMT Mgat5 À/À mice with a longer latency, but growth is observed in all mammary fat pads and often accelerated in the later stages, suggesting that there are genetic or epigenetic compensatory mechanisms (12) . Because RTKs are under tonic suppression by phosphatase in endosomes (13, 14) , we examined the possibility that redoxdependent suppression of these phosphotyrosine phosphatases (PTP) might promote ligand-independent growth signaling in PyMT Mgat5 (17) . At focal sites of RTK activation, Rac1 is recruited to the NADPH-dependent oxidase (NOX) complex, which catalyzes H 2 O 2 production (18) . PDGF (19) , EGF (20) , and stromelysin (matrix metalloproteinase-3) stimulate Rac1/H 2 O 2 and promote EMT in tumor cells (21) . However, most of the reactive oxygen species (ROS) in mammalian cells are generated in the mitochondria (22) . Elevated ROS in BCR-ABLtransformed cells are dependent on oncogenic activation of PI3K and mammalian target of rapamycin (mTOR), glucose uptake, and oxidative respiration (23) . Overexpression of Mox1, a NADPH oxidase that catalyzes H 2 O 2 production in a constitutive manner, is also transforming in NIH-3T3 cells (24) . Herein, we show that glucose uptake and mitochondrial ROS production promotes growth signaling in PyMT Mgat5
À/À tumor cells, compensating in part for cytokine insensitivity. Moreover, supplementation to complex N-glycan branching by Mgat5 expression or via the hexosamine pathway to UDP-GlcNAc promotes sensitivity to cytokines and control of glucose metabolism in tumor cells.
Materials and Methods
Cell lines. Tumor cell lines were established from spontaneous mammary carcinomas removed from PyMT transgenic mice on a 129sv Â FVB background with either Mgat5 +/+ or Mgat5 À/À genotypes (7, 12 ; Cell Signaling Technology), and g-tubulin (Sigma).
Cell cycle fluorescence-activated cell sorting. For serum starvation experiments, 5 Â 10 5 cells were plated per 10-cm tissue culture dish in fresh medium and cultured overnight, then washed with 1Â PBS, and incubated for the indicated times with serum-free DMEM. For GlcNAc titration, subconfluent cells were conditioned for 48 h in DMEM, 10% fetal bovine serum (FBS), and GlcNAc at the indicated concentrations. At the indicated times, cells were trypsinized, washed in PBS before fixation with 80% ethanol, and held at 4jC until completion of experiment. Cells were washed in PBS and then in PBS, 12% Triton-X, and 0.12 mmol/L EDTA, followed by incubation with DNase-free RNase A (1 Ag/mL) at 37jC for 30 min, and then stained with 50 Ag/mL propidium iodide for 1 h in the dark. FACSCalibur and cell cycle profile analysis with ModFitLT version 3.0 software were used to analyze the cells. Tumor cell sizes were compared using forward scatter (FSC) measurements on the fluorescence-activated cell sorting (FACS) and with a Coulter counter.
Glucose transport and ATP. Cells were seeded in triplicate at 2. The probe diffuses into the cells and, on oxidation, becomes fluorescent and trapped in the cell. The plate was incubated at 37jC for 30 min and fluorescence intensity of the oxidized probe at the bottom of each well was measured with excitation at 485-20 nm and emission at 530-25 nm using the Analyst HT plate reader (Molecular Devices) and the Criterion Host software (LJL Biosystems). Background fluorescence in the absence of probe was subtracted, and a standard curve for oxidation was generated using hydrogen peroxide. Results are plotted as the mean F SD of triplicate determination, and experiments were repeated thrice.
Translation rates. Cells were seeded in DMEM plus 10% FBS in triplicate at 2.5 Â 10 5 cells per well in six-well plates. At the given time, the medium was discarded and the cells were washed twice with PBS. Each well was equilibrated with DMEM methionine-free medium for 30 min at 37jC, then medium was removed, and DMEM methionine-free medium with 20 ACi [
35 S]methionine was added. The cells were treated for 30 min at 37jC. Following the incubation, the medium was removed and each well was washed twice with cold PBS, and then 200 AL of lysis buffer were added to each well. The cells were scraped from each well and then transferred to Eppendorfs. The samples were centrifuged at 14,000 Â g for 10 min at 4jC. The supernatants were removed and 10% TCA was added on ice for 30 min, and then proteins were trapped on GF-C filters (Whatman). The filters were washed thrice with 10% TCA and then washed once with 96% ethanol. The filter papers were air dried and [ 35 S]methionine incorporation was quantified by scintillation counting.
Nuclear translocation of p-Erk and Smad2/3. Cells plated in 96-well plates at 1,000 cells per well for 24 h were serum starved for a further 24 h and then stimulated with TGF-h1, EGF, or FBS. Cells were fixed after 40 min of TGF-h stimulation to measure Smad2/3 nuclear translocation and cells were fixed after 5 min of EGF stimulation to measure p-Erk nuclear translocation. Cells were fixed for 10 min with 3.7% formaldehyde at 20jC, washed with PBS plus 1% FBS, and permeabilized using 100% methanol for 2 min. The cells were washed thrice and blocked in PBS plus 10% FBS overnight at 4jC. Mouse anti-Smad2/3 (Transduction Laboratories) or mouse p-Erk1/2 (Thr 202 /Tyr 204 ; M-8159) was added at 1:1,000 in PBS plus 10% FBS for 2 h at 20jC. To measure nuclear phospho-p53 (Ser 15 ), cells were stained with antibodies (Cell Signaling Technology). The cells were washed thrice with PBS plus 1% FBS. Secondary antibody Alexa Fluor 488-labeled antimouse Ig (Molecular Probes) was added at 1:1,000 with Hoechst (1:2,000) for 1 h at 20jC. After washing thrice, the plates were scanned using the ArrayScan automated fluorescence microscope (Cellomics, Inc.). The nuclear staining intensity and cytoplasmic staining intensity were determined individually for 200 cells per well, and cytoplasmic staining intensity was subtracted from nuclear staining intensity for each cell. The mean F SE (n = 200) was generally <4% at each assay point. 96-well plates were cultured in DMEM and 1% FCS with each compound in the Sigma LOPAC(1280) library of pharmacologically active compounds at a final concentration of 5 Amol/L for 16 h. Drugs were added in duplicate wells using a BioMek-FX and incubated for 24 h, then 10 AL of AlamarBlue (Biosource) were added, and after a further 36 h at 37jC, plates were read using the Gemini XPS fluorometer (Molecular Devices) at 544 nm excitation/590 nm emission. The CellTiterGlo Luminescent Cell Viability Assay kit and the AlamarBlue assay produced similar results. Each plate contained eight positive (no cell treatment, PC) and eight negative (signal background, NC) controls. Data were normalized using the formula: (FI sample À mean FI NC ) / (mean FI PC À mean FI NC ) Â 100. ''Hits'' were defined as compounds associated with a signal that shifted by at least 3Â SD from the mean of the entire sample population. The Z factors were 0.58 and 0.53 for the Mgat +/+ and Mgat À/À screen, respectively, whereas the Z' factors were above 0. +/+ and Mgat5 À/À tumor cells growing in DMEM plus 10% FBS were serum starved for the indicated times. Cell lysates were applied to SDS-PAGE and probed for p-Akt, p-Erk, UCP-1, and g-tubulin.
increased apoptosis and a higher fraction of S and G 2 -M phase cells compared with Mgat5 +/+ cells (Fig. 1C) . More cells were observed in S-G 2 -M after 48 h in serum-free medium (SFM) compared with Mgat5 +/+ , reflecting a delay or failure of mutant cells to arrest in G 1 (Fig. 1C) . p-Erk and p-Akt levels declined in Mgat5 +/+ cells 24 to 48 h after serum withdrawal but remained elevated in Mgat5 À/À cells (Fig. 1D) . Nuclear p53(Ser 15 ) levels were lower in Mgat5
tumor cells under normal growth conditions, consistent with a weakened checkpoint (Supplementary Fig. S1A ). The M-phase blocker colcemid reduced growth of Mgat5-rescued mutant cells but not that of Mgat5 À/À tumor cells (Supplementary Fig. S1B ).
Similarly, the S-phase blocker hydroxyurea slowed Mgat5-rescued cells but was less effective on Mgat5 À/À tumor cells (Supplementary Fig. S1C ). These experiments indicate that PyMT Mgat5
À/À cells are functionally deficient in G 1 -S and G 2 -M checkpoints and suggest that shorter pauses in interphase result in reduced cell size. Mgat5-and PyMT-dependent control of metabolism. Although PI3K/Akt activation is known to stimulate glucose uptake (27) , we explored the converse relationship: whether hyperglucose metabolism in Mgat5
À/À cells contributes to PI3K/Akt signaling.
Glucose uptake rates were similar in Mgat5 +/+ , Mgat5 À/À , and
Mgat5-rescued cell lines cultured in serum-containing medium, but after 24 h in SFM, Mgat5 +/+ and Mgat5-rescued cells showed strong down-regulation, whereas glucose uptake remained unchanged in Mgat5
À/À cells at 24 h and showed an increase by 72 h (Fig. 2A) . GLUT1 gene expression is increased by oncogenic transformation of cultured cells and correlates with poor survival of cancer patients (28) . Glut1 protein levels were 2-to 3-fold higher in Mgat5 À/À cells compared with Mgat5 +/+ cells (Fig. 2B ). Glucose transport V max was 6-fold higher in Mgat5 À/À compared with Mgat5 +/+ cells, whereas K D values were similar indicating that Mgat5-dependent N-glycosylation did not alter the kinetics of transport (Fig. 2C) . After 24 h in SFM, ROS levels decreased in Mgat5 +/+ tumor cells but increased 2-fold in Mgat5 À/À tumor cells (Fig. 2D) uptake in nontransformed cells, but this requirement is removed by the PyMT oncoprotein, which drives a glucose-dependent positive feedback loop. However, Mgat5 expression seems to be required in PyMT-transformed cells to sense serum withdrawal and suppress growth.
Translational initiation and elongation are positively regulated by Akt/mTOR and inhibited by AMP-activated protein kinase (AMPK; refs. 30, 31). ATP levels were 2-fold higher in Mgat5 À/À cells and increased further upon transfer to SFM, whereas ATP was unchanged in Mgat5 +/+ cells (Fig. 3A) (Fig. 4B ). Mgat5 À/À cells treated with rapamycin, an mTOR inhibitor, displayed a decrease in ROS production, whereas glucose uptake was reduced by treatment with rapamycin or the PI3K inhibitor LY294002 (Fig. 4C and D) . ROS levels were unaffected in Mgat5 +/+ cells, whereas glucose uptake was reduced by LY294002. This indicates that high ROS production in Mgat5 À/À cells is dependent in part on PI3K/mTOR activation of metabolism. Mitochondrial ROS is suppressed by the uncoupling proteins (UCP), which catalyze a controlled leakage of protons across the inner membrane. UCP-1 levels were lower in Mgat5 À/À tumor cells than Mgat5 +/+ cells, and following serum withdrawal, UCP-1 increased in Mgat5 À/À tumor cells and decreased in Mgat5 +/+ cells (Fig. 1C) . UCP-1 expression is stimulated by superoxides (22) , which may provide negative feedback to suppress mitochondrial ROS production. ROS stimulates antioxidant pathways that limit damage (34) (Fig. 5A) . However, Erk phosphorylation recovered more rapidly in Mgat5 À/À compared with Mgat5 +/+ tumor cells in SFM conditions (Fig. 5B) . This suggests that anti-oxidant pathways SFM, suggesting that h1,6GlcNAc-branched N-glycans may also be required to suppress growth signaling. N-glycan branching is increased with GlcNAc supplementation to the culture medium, and this enhances galectin-dependent binding and retention of receptor at the cell surface (8) . GlcNAc is salvaged by the hexosamine pathway and increases UDP-GlcNAc supply to Golgi N-acetylglucosaminyltransferases (Mgat1, Mgat2, Mgat4a/b, and Mgat5; Supplementary Fig. S3A ). GlcNAc supplementation does not restore h1,6GlcNAc-branched N-glycans in Mgat5
À/À cells but rather increases the fraction of the next most branched N-glycan (tri-antennary) from 15% to 30% of the total N-glycan pool (8) . The tri-antennary and tetra-antennary N-glycans in Mgat5 +/+ cells increase only marginally with GlcNAc supplementation, suggesting that the medial Golgi pathway in Mgat5 +/+ tumor cells is operating closer to saturation for UDP-GlcNAc (8) . Activation of PI3K and Erk pathways in transformed cells increases Mgat4, Mgat5, and h1,3N-acetylglucosaminyltransferase expression (35) (36) (37) , which reduces the apparent D 50 of the pathway for UDP-GlcNAc. This effectively decreases the sensitivity of pathway end products to UDP-GlcNAc below estimated physiologic concentration of f1.5 mmol/L (8) .
Surface levels of ThR in Mgat5 À/À were lower than Mgat5 +/+ cells, and GlcNAc supplementation increased ThR to comparable levels for both cell lines (Supplementary Fig. S3B ). Surface levels of EGFR were partially rescued in Mgat5 À/À cells by GlcNAc supplementation (8) , and acute responsiveness to both EGF and TGF-h was largely restored (Supplementary Fig. S3C and D) . Thus, an increase in the less branched tri-antennary N-glycans is sufficient to restore the surface residency of receptors in Mgat5
À/À cells. Importantly, GlcNAc supplementation normalized glucose and ROS transport in Mgat5 À/À cells under low serum conditions (Fig. 6A) . GlcNAc suppressed the growth of Mgat5 À/À tumor cells to a greater degree than Mgat5 +/+ tumor cells ( Fig. 6B ; Supplementary  Fig. S4A-C Fig. 6B ; Supplementary  Fig. S4A-C) . The cell cycle profile in Mgat5 +/+ cells was less severely affected by GlcNAc, with only a small increase in the S-phase population. GlcNAc supplementation restored basal nuclear phospho-Smad2/3 (p-Smad2/3) in Mgat5
À/À cells to levels comparable with that of Mgat5 +/+ cells, presumably reflecting enhanced sensitivity to autocrine/paracrine TGF-h. Similarly, À/À cells cultured in DMEM plus 10% FBS supplemented with GlcNAc for 48 h (cell cycle distribution is in Supplementary Fig. S4 ). C, tonic levels of nuclear p-Erk and p-Smad2 expressed as a ratio in Mgat5 +/+ and Mgat5 À/À cells following 48 h of GlcNAc supplementation in normal growth conditions. D, a model of N -glycan-dependent regulation of cytokine receptors and metabolism. The PyMT oncoprotein directly activates PI3K/Akt, promoting positive feedback to glucose uptake. Glucose metabolism increases ROS, thus oxidation of signaling intermediates that stimulate growth. Metabolic flux to the hexosamine and N -glycan branching pathway and/or Mgat5 expression increases affinities for galectin and surface residency of cytokine receptors in a lattice microdomain (see ref. 8) . RTKs that promote growth have relatively high numbers of N -glycans with 11.4 F 5.1 N-X-S/T consensus sequences (n = 30 receptor) and estimated to be f70% occupancy. Receptor kinases with low multiplicity function in organogenesis and differentiation/arrest include Tie1, Musk, Ltk, ROR1/2, DDR1, the Eph receptors, and TGF-h/BMP receptors (27 receptors 2.48 F 1.28 N-X-S/T sites/ receptor). In Mgat5 À/À cells, insufficient positive feedback from the cell surface (1) is partially alleviated by ROS-dependent activation of growth signaling intermediates (green ) in the endosomes. However, positive feedback via the hexosamine/N-glycan processing is also insufficient to maintain (2 ) ThR and other low receptors with few N -glycans at levels sufficient to retrain the cell cycle. In PyMT Mgat5 +/+ cells, RTKs attain higher affinities for galectins and are retained at the cell surface in greater numbers and dominate over ThR and other low receptors.
GlcNAc partially restored basal nuclear p-Erk in serum-depleted conditions ( Supplementary Fig. S3C and D) . In culture conditions with serum, the ratio of p-Erk to p-Smad2/3 in Mgat5 À/À cells decreased with GlcNAc supplementation but much less in Mgat5 +/+ cells (Fig. 6C) . TGF-h/Smad and PI3K/Erk pathways are antagonistic at multiple levels (5, 38) and therefore likely to play a role in growth control as has been observed in Caenorhabditis elegans (39) . Our results show that Mgat5 products, the h1,6GlcNAc-branched N-glycans, are required to balance growth and arrest signaling in PyMT tumor cells (Fig. 6D) .
Discussion
Tumor progression in PyMT transgenic mice is slower in Mgat5 À/À mice than in WT mice, and Mgat5 À/À mammary tumor cells established in tissue culture are deficient in responsiveness to multiple ligands (7, 12) . The elevated energy charge in Mgat5 À/À tumor is expected to suppress negative regulation of mTOR/S6K by AMPK (40) . Indeed, depletion of S6K1 or mutation of the S6K phosphorylation sites in S6 decreases cell size and increases protein synthesis rates, similar in this regard to the phenotype of the PyMT Mgat5 À/À tumor cells (41) . Interestingly, nutrient restriction in Drosophila AMPKadeficient epithelial cells results in loss of polarity and overproliferation, suggesting that changes in basic metabolism are an important aspect of the cancerous phenotype (42) . ROS has been shown to activate mTOR in cultured human cells, whereas S6K1 phosphorylation becomes insensitive to nutrient deprivation (43) . We suggest that ROS-dependent growth signaling and changes in metabolite flux to N-glycan biosynthesis may be critical determinants of cell size and growth autonomy. Activation of EGFR at the plasma membrane by EGF stimulates PI3K/Akt signaling and H 2 O 2 production via Rac1/NOX in a transient and localized manner that promotes polarization of microfilaments and cell motility (13) . In contrast, ROS generated by the electron transport chain is likely to be persistent, and nonpolarized, as mitochondria are generally distributed in the cell. Moreover, activation of EGFR by H 2 O 2 or EGF induces different patterns of receptor phosphorylation, which can affect signaling dynamics. The c-Cbl binding site at Tyr 1045 is under phosphorylation by H 2 O 2 stimulation, whereas four other sites common to EGFR stimulation are phosphorylated. As such, H 2 O 2 prolongs EGFR activation by slowing ubiquitination and transit to the endosomes where inactivation occurs by PTPs (44) . Near saturating levels of phosphatase activities are required to maintain the sensitivity of cytokine receptors to ligands. For example, EGFR is under tonic phosphatase suppression in endomembrane compartments, but redox-dependent suppression of PTPs in the endosomes promotes ligand-independent activation (13, 14 (46, 47) , which drives expression of checkpoint, DNA repair, and anti-oxidant proteins, including GADD45, cyclin B, plk1, mSOD, and p27 Kip1 (48) . Of these competing effects, glucose metabolism and checkpoint dysfunction prevail in PyMT Mgat5 Both GlcNAc supplementation and Mgat5 expression promote receptor binding to galectins and shift receptor residency from the endosomes (ROS-dependent RTKs) to the cell surface (ligand dependent), but with qualitative differences. GlcNAc supplementation fully rescued surface ThRII receptor, which has only two N-glycans, whereas EGFR with eight N-glycans remains partially dependent on Mgat5 for optimal hexosamine-dependent surface expression (8) .
In keeping with this relationship, increasing GlcNAc supplementation reduced the nuclear p-Erk/p-Smad2/3 ratio in Mgat5 À/À tumor cells, as well as glucose uptake and proliferation, whereas GlcNAc had a more modest effect on Mgat5 +/+ cells (Fig. 6D ). Mgat5 expression commonly increases in oncogene-transformed cells, and predictions based on computational modeling indicate that Mgat5 products preferentially increase the surface levels of growth receptors (high number of N-glycans), relative to ThRII and other glycoproteins with few N-glycans (8). Our results suggest that nutrient flux to complex N-glycan biosynthesis coordinates the cellular response to multiple extracellular cues in tumor cells that determine growth, invasion, and sensitivity to drugs.
